Royce & Associates’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-28,064	Closed	-$90K	–	937
2022 Q3	$90K	Hold	28,064	–	–	﹤0.01%	904
2022 Q2	$55K	Hold	28,064	–	–	﹤0.01%	930
2022 Q1	$114K	Hold	28,064	–	–	﹤0.01%	946
2021 Q4	$303K	Hold	28,064	–	–	﹤0.01%	931
2021 Q3	$324K	Hold	28,064	–	–	﹤0.01%	946
2021 Q2	$276K	Hold	28,064	–	–	﹤0.01%	970
2021 Q1	$410K	Hold	28,064	–	–	﹤0.01%	963
2020 Q4	$601K	Hold	28,064	–	–	0.01%	866
2020 Q3	$426K	Hold	28,064	–	–	﹤0.01%	873
2020 Q2	$361K	Sell	28,064 -1	-0%	-$13	﹤0.01%	888
2020 Q1	$259K	Hold	28,065	–	–	﹤0.01%	891
2019 Q4	$374K	Hold	28,065	–	–	﹤0.01%	919
2019 Q3	$249K	Hold	28,065	–	–	﹤0.01%	970
2019 Q2	$401K	Hold	28,065	–	–	﹤0.01%	933
2019 Q1	$923K	Hold	28,065	–	–	0.01%	866
2018 Q4	$1.67M	Sell	28,065 -9,050	-24%	-$538K	0.01%	779
2018 Q3	$5.21M	Sell	37,115 -1,667	-4%	-$234K	0.04%	587
2018 Q2	$4.76M	Hold	38,782	–	–	0.03%	603
2018 Q1	$3.47M	Sell	38,782 -6,926	-15%	-$619K	0.02%	680
2017 Q4	$2.53M	Buy	45,708 +18,000	+65%	+$998K	0.02%	790
2017 Q3	$1.17M	Hold	27,708	–	–	0.01%	923
2017 Q2	$1.17M	Sell	27,708 -4,083	-13%	-$172K	0.01%	936
2017 Q1	$1.78M	Sell	31,791 -10,215	-24%	-$571K	0.01%	888
2016 Q4	$1.6M	Hold	42,006	–	–	0.01%	868
2016 Q3	$1.67M	Buy	+42,006	New	+$1.67M	0.01%	849